Valbonne, France

René Gimet


Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 23(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of René Gimet

Introduction

René Gimet is a notable inventor based in Valbonne, France. He has made significant contributions to the field of pharmaceutical formulations, particularly focusing on fast-dissolving tablets. With a total of two patents to his name, Gimet's work has the potential to impact the way medications are delivered and consumed.

Latest Patents

Gimet's latest patents include "Galenic formulations fast disintegrating in the mouth and method for preparing same" and "Dispersible macrolide compounds and method for production thereof." The first patent addresses the development of dispersible tablets containing macrolides as active ingredients, which can be used alone or in combination with other active ingredients. The tablets are characterized by the presence of macrolides such as pristinamycin, azithromycin, roxithromycin, clarithromycin, and spiramycin, which are included in proportions ranging from 20-60% of the total weight. Additionally, these tablets contain at least one disintegrator in proportions ranging from 1-25% of the total weight, along with at least one sweetening agent.

Career Highlights

Throughout his career, Gimet has worked with various companies, including Cll Pharma and Ccl Pharma. His experience in these organizations has allowed him to refine his expertise in pharmaceutical innovations and contribute to the development of new products.

Collaborations

Gimet has collaborated with notable individuals in his field, including Claude Laruelle and Noël Zakarian. These partnerships have likely enhanced his research and development efforts, leading to the successful creation of his patented formulations.

Conclusion

René Gimet's contributions to the pharmaceutical industry through his innovative patents demonstrate his commitment to improving medication delivery systems. His work continues to influence the development of effective and user-friendly pharmaceutical products.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…